nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—ABCB1—ovarian cancer	0.207	1	CbGaD
Phenytoin—ABCC2—Paclitaxel—ovarian cancer	0.0491	0.0952	CbGbCtD
Phenytoin—ABCC2—Carboplatin—ovarian cancer	0.0462	0.0896	CbGbCtD
Phenytoin—ABCC2—Docetaxel—ovarian cancer	0.0355	0.0688	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0328	0.0636	CbGbCtD
Phenytoin—CYP3A7—Paclitaxel—ovarian cancer	0.0328	0.0636	CbGbCtD
Phenytoin—ABCB1—Topotecan—ovarian cancer	0.0324	0.0627	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—ovarian cancer	0.0265	0.0513	CbGbCtD
Phenytoin—CYP3A5—Paclitaxel—ovarian cancer	0.0246	0.0477	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0237	0.046	CbGbCtD
Phenytoin—CYP3A7—Docetaxel—ovarian cancer	0.0237	0.046	CbGbCtD
Phenytoin—CYP2C8—Paclitaxel—ovarian cancer	0.0237	0.0459	CbGbCtD
Phenytoin—ABCB1—Vinorelbine—ovarian cancer	0.0228	0.0442	CbGbCtD
Phenytoin—CYP3A4—Topotecan—ovarian cancer	0.0194	0.0376	CbGbCtD
Phenytoin—CYP3A5—Docetaxel—ovarian cancer	0.0178	0.0345	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—ovarian cancer	0.0168	0.0326	CbGbCtD
Phenytoin—CYP2C9—Paclitaxel—ovarian cancer	0.0165	0.032	CbGbCtD
Phenytoin—ABCB1—Paclitaxel—ovarian cancer	0.016	0.031	CbGbCtD
Phenytoin—CYP3A4—Vinorelbine—ovarian cancer	0.0137	0.0265	CbGbCtD
Phenytoin—ABCB1—Docetaxel—ovarian cancer	0.0116	0.0224	CbGbCtD
Phenytoin—CYP3A4—Paclitaxel—ovarian cancer	0.0096	0.0186	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—ovarian cancer	0.00863	0.0167	CbGbCtD
Phenytoin—CYP3A4—Docetaxel—ovarian cancer	0.00694	0.0134	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—ovarian cancer	0.00517	0.01	CbGbCtD
Phenytoin—CYP2C18—uterine cervix—ovarian cancer	0.000721	0.0641	CbGeAlD
Phenytoin—CYP2C18—vagina—ovarian cancer	0.000488	0.0434	CbGeAlD
Phenytoin—SCN8A—testis—ovarian cancer	0.000473	0.042	CbGeAlD
Phenytoin—SCN3A—decidua—ovarian cancer	0.000454	0.0404	CbGeAlD
Phenytoin—SCN9A—testis—ovarian cancer	0.000415	0.0369	CbGeAlD
Phenytoin—SLCO1C1—testis—ovarian cancer	0.000403	0.0359	CbGeAlD
Phenytoin—SCN4A—testis—ovarian cancer	0.00037	0.0329	CbGeAlD
Phenytoin—SCN2A—vagina—ovarian cancer	0.000367	0.0327	CbGeAlD
Phenytoin—SCN3A—female reproductive system—ovarian cancer	0.000357	0.0318	CbGeAlD
Phenytoin—SCN3A—bone marrow—ovarian cancer	0.000337	0.03	CbGeAlD
Phenytoin—SCN3A—vagina—ovarian cancer	0.000323	0.0287	CbGeAlD
Phenytoin—SCN5A—vagina—ovarian cancer	0.000322	0.0286	CbGeAlD
Phenytoin—SCN9A—lymph node—ovarian cancer	0.000301	0.0268	CbGeAlD
Phenytoin—SLCO1C1—lymph node—ovarian cancer	0.000292	0.026	CbGeAlD
Phenytoin—SCN3A—testis—ovarian cancer	0.000288	0.0256	CbGeAlD
Phenytoin—ABCC2—female reproductive system—ovarian cancer	0.000267	0.0237	CbGeAlD
Phenytoin—CYP2C8—endometrium—ovarian cancer	0.000242	0.0215	CbGeAlD
Phenytoin—CYP3A5—uterine cervix—ovarian cancer	0.000241	0.0215	CbGeAlD
Phenytoin—ALB—testis—ovarian cancer	0.00023	0.0205	CbGeAlD
Phenytoin—ABCC2—testis—ovarian cancer	0.000216	0.0192	CbGeAlD
Phenytoin—SCN3A—lymph node—ovarian cancer	0.000209	0.0186	CbGeAlD
Phenytoin—CYP2C19—vagina—ovarian cancer	0.000208	0.0185	CbGeAlD
Phenytoin—CYP2B6—gonad—ovarian cancer	0.000201	0.0179	CbGeAlD
Phenytoin—CYP2C8—female reproductive system—ovarian cancer	0.0002	0.0178	CbGeAlD
Phenytoin—CYP2C8—vagina—ovarian cancer	0.000181	0.0161	CbGeAlD
Phenytoin—CYP2B6—female reproductive system—ovarian cancer	0.00018	0.016	CbGeAlD
Phenytoin—CYP2C9—female reproductive system—ovarian cancer	0.000178	0.0158	CbGeAlD
Phenytoin—ALB—lymph node—ovarian cancer	0.000167	0.0148	CbGeAlD
Phenytoin—ABCB1—myometrium—ovarian cancer	0.000165	0.0146	CbGeAlD
Phenytoin—CYP3A5—female gonad—ovarian cancer	0.000164	0.0146	CbGeAlD
Phenytoin—CYP3A5—vagina—ovarian cancer	0.000163	0.0145	CbGeAlD
Phenytoin—CYP2B6—vagina—ovarian cancer	0.000162	0.0145	CbGeAlD
Phenytoin—CYP2C8—testis—ovarian cancer	0.000162	0.0144	CbGeAlD
Phenytoin—ABCB1—embryo—ovarian cancer	0.000158	0.0141	CbGeAlD
Phenytoin—ABCC2—lymph node—ovarian cancer	0.000156	0.0139	CbGeAlD
Phenytoin—CYP2B6—testis—ovarian cancer	0.000145	0.0129	CbGeAlD
Phenytoin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000145	0.000621	CcSEcCtD
Phenytoin—Tachycardia—Paclitaxel—ovarian cancer	0.000144	0.000619	CcSEcCtD
Phenytoin—Breast disorder—Doxorubicin—ovarian cancer	0.000144	0.000617	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000143	0.000615	CcSEcCtD
Phenytoin—Bronchitis—Epirubicin—ovarian cancer	0.000143	0.000613	CcSEcCtD
Phenytoin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000143	0.000613	CcSEcCtD
Phenytoin—Anaemia—Docetaxel—ovarian cancer	0.000142	0.000609	CcSEcCtD
Phenytoin—Pancytopenia—Epirubicin—ovarian cancer	0.000141	0.000606	CcSEcCtD
Phenytoin—Anorexia—Paclitaxel—ovarian cancer	0.000141	0.000605	CcSEcCtD
Phenytoin—Gastritis—Doxorubicin—ovarian cancer	0.000141	0.000604	CcSEcCtD
Phenytoin—Muscular weakness—Doxorubicin—ovarian cancer	0.00014	0.000602	CcSEcCtD
Phenytoin—Vomiting—Vinorelbine—ovarian cancer	0.00014	0.0006	CcSEcCtD
Phenytoin—Dysuria—Epirubicin—ovarian cancer	0.000139	0.000596	CcSEcCtD
Phenytoin—Rash—Vinorelbine—ovarian cancer	0.000139	0.000595	CcSEcCtD
Phenytoin—Dermatitis—Vinorelbine—ovarian cancer	0.000138	0.000594	CcSEcCtD
Phenytoin—Hypotension—Paclitaxel—ovarian cancer	0.000138	0.000593	CcSEcCtD
Phenytoin—Headache—Vinorelbine—ovarian cancer	0.000138	0.000591	CcSEcCtD
Phenytoin—Syncope—Docetaxel—ovarian cancer	0.000138	0.000591	CcSEcCtD
Phenytoin—Influenza—Doxorubicin—ovarian cancer	0.000137	0.00059	CcSEcCtD
Phenytoin—Asthma—Doxorubicin—ovarian cancer	0.000137	0.00059	CcSEcCtD
Phenytoin—Dysphagia—Doxorubicin—ovarian cancer	0.000137	0.00059	CcSEcCtD
Phenytoin—Leukopenia—Docetaxel—ovarian cancer	0.000137	0.00059	CcSEcCtD
Phenytoin—Eosinophilia—Doxorubicin—ovarian cancer	0.000136	0.000584	CcSEcCtD
Phenytoin—CYP3A4—female reproductive system—ovarian cancer	0.000136	0.0121	CbGeAlD
Phenytoin—Palpitations—Docetaxel—ovarian cancer	0.000136	0.000582	CcSEcCtD
Phenytoin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000136	0.000582	CcSEcCtD
Phenytoin—Loss of consciousness—Docetaxel—ovarian cancer	0.000135	0.000579	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000135	0.000578	CcSEcCtD
Phenytoin—Weight decreased—Epirubicin—ovarian cancer	0.000134	0.000577	CcSEcCtD
Phenytoin—Hyperglycaemia—Epirubicin—ovarian cancer	0.000134	0.000575	CcSEcCtD
Phenytoin—Cough—Docetaxel—ovarian cancer	0.000134	0.000575	CcSEcCtD
Phenytoin—Insomnia—Paclitaxel—ovarian cancer	0.000134	0.000574	CcSEcCtD
Phenytoin—Pneumonia—Epirubicin—ovarian cancer	0.000133	0.000572	CcSEcCtD
Phenytoin—Convulsion—Docetaxel—ovarian cancer	0.000133	0.000571	CcSEcCtD
Phenytoin—Paraesthesia—Paclitaxel—ovarian cancer	0.000133	0.00057	CcSEcCtD
Phenytoin—Hypertension—Docetaxel—ovarian cancer	0.000133	0.000569	CcSEcCtD
Phenytoin—Drowsiness—Epirubicin—ovarian cancer	0.000132	0.000569	CcSEcCtD
Phenytoin—Bronchitis—Doxorubicin—ovarian cancer	0.000132	0.000568	CcSEcCtD
Phenytoin—Dyspnoea—Paclitaxel—ovarian cancer	0.000132	0.000566	CcSEcCtD
Phenytoin—Somnolence—Paclitaxel—ovarian cancer	0.000131	0.000564	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000131	0.000564	CcSEcCtD
Phenytoin—Myalgia—Docetaxel—ovarian cancer	0.000131	0.000561	CcSEcCtD
Phenytoin—Arthralgia—Docetaxel—ovarian cancer	0.000131	0.000561	CcSEcCtD
Phenytoin—Chest pain—Docetaxel—ovarian cancer	0.000131	0.000561	CcSEcCtD
Phenytoin—Pancytopenia—Doxorubicin—ovarian cancer	0.000131	0.00056	CcSEcCtD
Phenytoin—Nausea—Vinorelbine—ovarian cancer	0.000131	0.00056	CcSEcCtD
Phenytoin—Renal failure—Epirubicin—ovarian cancer	0.00013	0.000559	CcSEcCtD
Phenytoin—Dyspepsia—Paclitaxel—ovarian cancer	0.00013	0.000558	CcSEcCtD
Phenytoin—ABCB1—epithelium—ovarian cancer	0.000129	0.0115	CbGeAlD
Phenytoin—Conjunctivitis—Epirubicin—ovarian cancer	0.000129	0.000553	CcSEcCtD
Phenytoin—Dysuria—Doxorubicin—ovarian cancer	0.000129	0.000552	CcSEcCtD
Phenytoin—Decreased appetite—Paclitaxel—ovarian cancer	0.000128	0.000551	CcSEcCtD
Phenytoin—ABCB1—uterine cervix—ovarian cancer	0.000128	0.0114	CbGeAlD
Phenytoin—Dry mouth—Docetaxel—ovarian cancer	0.000128	0.000549	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000128	0.000548	CcSEcCtD
Phenytoin—Fatigue—Paclitaxel—ovarian cancer	0.000127	0.000547	CcSEcCtD
Phenytoin—Sweating—Epirubicin—ovarian cancer	0.000127	0.000545	CcSEcCtD
Phenytoin—Constipation—Paclitaxel—ovarian cancer	0.000126	0.000542	CcSEcCtD
Phenytoin—Confusional state—Docetaxel—ovarian cancer	0.000126	0.000542	CcSEcCtD
Phenytoin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000125	0.000539	CcSEcCtD
Phenytoin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000125	0.000538	CcSEcCtD
Phenytoin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000125	0.000538	CcSEcCtD
Phenytoin—Epistaxis—Epirubicin—ovarian cancer	0.000125	0.000536	CcSEcCtD
Phenytoin—Infection—Docetaxel—ovarian cancer	0.000124	0.000534	CcSEcCtD
Phenytoin—Weight decreased—Doxorubicin—ovarian cancer	0.000124	0.000534	CcSEcCtD
Phenytoin—Sinusitis—Epirubicin—ovarian cancer	0.000124	0.000533	CcSEcCtD
Phenytoin—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000124	0.000532	CcSEcCtD
Phenytoin—Agranulocytosis—Epirubicin—ovarian cancer	0.000124	0.000531	CcSEcCtD
Phenytoin—Pneumonia—Doxorubicin—ovarian cancer	0.000123	0.000529	CcSEcCtD
Phenytoin—Shock—Docetaxel—ovarian cancer	0.000123	0.000529	CcSEcCtD
Phenytoin—Nervous system disorder—Docetaxel—ovarian cancer	0.000123	0.000527	CcSEcCtD
Phenytoin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000123	0.000526	CcSEcCtD
Phenytoin—Drowsiness—Doxorubicin—ovarian cancer	0.000123	0.000526	CcSEcCtD
Phenytoin—Tachycardia—Docetaxel—ovarian cancer	0.000122	0.000525	CcSEcCtD
Phenytoin—ABCB1—decidua—ovarian cancer	0.000122	0.0109	CbGeAlD
Phenytoin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000122	0.000523	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000122	0.000522	CcSEcCtD
Phenytoin—Bradycardia—Epirubicin—ovarian cancer	0.000121	0.00052	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—ovarian cancer	0.00012	0.000517	CcSEcCtD
Phenytoin—Haemoglobin—Epirubicin—ovarian cancer	0.00012	0.000513	CcSEcCtD
Phenytoin—Anorexia—Docetaxel—ovarian cancer	0.000119	0.000513	CcSEcCtD
Phenytoin—Rhinitis—Epirubicin—ovarian cancer	0.000119	0.000512	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000119	0.000511	CcSEcCtD
Phenytoin—Haemorrhage—Epirubicin—ovarian cancer	0.000119	0.00051	CcSEcCtD
Phenytoin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000118	0.000508	CcSEcCtD
Phenytoin—Pharyngitis—Epirubicin—ovarian cancer	0.000118	0.000507	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—ovarian cancer	0.000118	0.000504	CcSEcCtD
Phenytoin—Urticaria—Paclitaxel—ovarian cancer	0.000117	0.000504	CcSEcCtD
Phenytoin—Hypotension—Docetaxel—ovarian cancer	0.000117	0.000502	CcSEcCtD
Phenytoin—Connective tissue disorder—Epirubicin—ovarian cancer	0.000117	0.000502	CcSEcCtD
Phenytoin—Body temperature increased—Paclitaxel—ovarian cancer	0.000117	0.000501	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000116	0.000498	CcSEcCtD
Phenytoin—ABCB1—endometrium—ovarian cancer	0.000116	0.0103	CbGeAlD
Phenytoin—Epistaxis—Doxorubicin—ovarian cancer	0.000116	0.000496	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—ovarian cancer	0.000115	0.000494	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000114	0.000491	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000114	0.00049	CcSEcCtD
Phenytoin—Insomnia—Docetaxel—ovarian cancer	0.000113	0.000486	CcSEcCtD
Phenytoin—Paraesthesia—Docetaxel—ovarian cancer	0.000112	0.000483	CcSEcCtD
Phenytoin—Erythema multiforme—Epirubicin—ovarian cancer	0.000112	0.000483	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—ovarian cancer	0.000112	0.000481	CcSEcCtD
Phenytoin—Dyspnoea—Docetaxel—ovarian cancer	0.000112	0.000479	CcSEcCtD
Phenytoin—Somnolence—Docetaxel—ovarian cancer	0.000111	0.000478	CcSEcCtD
Phenytoin—Tinnitus—Epirubicin—ovarian cancer	0.000111	0.000476	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—ovarian cancer	0.000111	0.000475	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—ovarian cancer	0.00011	0.000474	CcSEcCtD
Phenytoin—Dyspepsia—Docetaxel—ovarian cancer	0.00011	0.000473	CcSEcCtD
Phenytoin—Haemorrhage—Doxorubicin—ovarian cancer	0.00011	0.000472	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000109	0.00047	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—ovarian cancer	0.000109	0.000469	CcSEcCtD
Phenytoin—Decreased appetite—Docetaxel—ovarian cancer	0.000109	0.000467	CcSEcCtD
Phenytoin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000109	0.000467	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000108	0.000464	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000108	0.000464	CcSEcCtD
Phenytoin—Fatigue—Docetaxel—ovarian cancer	0.000108	0.000464	CcSEcCtD
Phenytoin—ABCB1—gonad—ovarian cancer	0.000108	0.00956	CbGeAlD
Phenytoin—Immune system disorder—Epirubicin—ovarian cancer	0.000107	0.000461	CcSEcCtD
Phenytoin—Constipation—Docetaxel—ovarian cancer	0.000107	0.00046	CcSEcCtD
Phenytoin—ABCB1—uterus—ovarian cancer	0.000107	0.0095	CbGeAlD
Phenytoin—Chills—Epirubicin—ovarian cancer	0.000107	0.000458	CcSEcCtD
Phenytoin—Asthenia—Paclitaxel—ovarian cancer	0.000106	0.000455	CcSEcCtD
Phenytoin—Pruritus—Paclitaxel—ovarian cancer	0.000105	0.000449	CcSEcCtD
Phenytoin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000104	0.000447	CcSEcCtD
Phenytoin—Feeling abnormal—Docetaxel—ovarian cancer	0.000103	0.000443	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—ovarian cancer	0.000103	0.00044	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—ovarian cancer	0.000102	0.000438	CcSEcCtD
Phenytoin—Tension—Epirubicin—ovarian cancer	0.000102	0.000436	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—ovarian cancer	0.000101	0.000435	CcSEcCtD
Phenytoin—Diarrhoea—Paclitaxel—ovarian cancer	0.000101	0.000434	CcSEcCtD
Phenytoin—Nervousness—Epirubicin—ovarian cancer	0.000101	0.000432	CcSEcCtD
Phenytoin—Back pain—Epirubicin—ovarian cancer	0.0001	0.00043	CcSEcCtD
Phenytoin—Muscle spasms—Epirubicin—ovarian cancer	9.95e-05	0.000427	CcSEcCtD
Phenytoin—Immune system disorder—Doxorubicin—ovarian cancer	9.94e-05	0.000427	CcSEcCtD
Phenytoin—Body temperature increased—Docetaxel—ovarian cancer	9.9e-05	0.000425	CcSEcCtD
Phenytoin—Chills—Doxorubicin—ovarian cancer	9.87e-05	0.000424	CcSEcCtD
Phenytoin—Dizziness—Paclitaxel—ovarian cancer	9.77e-05	0.000419	CcSEcCtD
Phenytoin—Ill-defined disorder—Epirubicin—ovarian cancer	9.61e-05	0.000412	CcSEcCtD
Phenytoin—ABCB1—female reproductive system—ovarian cancer	9.6e-05	0.00854	CbGeAlD
Phenytoin—Anaemia—Epirubicin—ovarian cancer	9.57e-05	0.000411	CcSEcCtD
Phenytoin—Agitation—Epirubicin—ovarian cancer	9.51e-05	0.000408	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—ovarian cancer	9.44e-05	0.000405	CcSEcCtD
Phenytoin—Tension—Doxorubicin—ovarian cancer	9.4e-05	0.000403	CcSEcCtD
Phenytoin—Vomiting—Paclitaxel—ovarian cancer	9.4e-05	0.000403	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—ovarian cancer	9.38e-05	0.000403	CcSEcCtD
Phenytoin—Malaise—Epirubicin—ovarian cancer	9.34e-05	0.000401	CcSEcCtD
Phenytoin—Rash—Paclitaxel—ovarian cancer	9.32e-05	0.0004	CcSEcCtD
Phenytoin—Dermatitis—Paclitaxel—ovarian cancer	9.31e-05	0.0004	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—ovarian cancer	9.3e-05	0.000399	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—ovarian cancer	9.3e-05	0.000399	CcSEcCtD
Phenytoin—Syncope—Epirubicin—ovarian cancer	9.28e-05	0.000399	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—ovarian cancer	9.27e-05	0.000398	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—ovarian cancer	9.27e-05	0.000398	CcSEcCtD
Phenytoin—Headache—Paclitaxel—ovarian cancer	9.26e-05	0.000397	CcSEcCtD
Phenytoin—Hypersensitivity—Docetaxel—ovarian cancer	9.23e-05	0.000396	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—ovarian cancer	9.21e-05	0.000395	CcSEcCtD
Phenytoin—Palpitations—Epirubicin—ovarian cancer	9.15e-05	0.000393	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—ovarian cancer	9.1e-05	0.000391	CcSEcCtD
Phenytoin—ABCB1—bone marrow—ovarian cancer	9.07e-05	0.00806	CbGeAlD
Phenytoin—Cough—Epirubicin—ovarian cancer	9.03e-05	0.000388	CcSEcCtD
Phenytoin—Asthenia—Docetaxel—ovarian cancer	8.99e-05	0.000386	CcSEcCtD
Phenytoin—Convulsion—Epirubicin—ovarian cancer	8.97e-05	0.000385	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—ovarian cancer	8.94e-05	0.000384	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—ovarian cancer	8.89e-05	0.000382	CcSEcCtD
Phenytoin—Pruritus—Docetaxel—ovarian cancer	8.86e-05	0.00038	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—ovarian cancer	8.85e-05	0.00038	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—ovarian cancer	8.81e-05	0.000378	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—ovarian cancer	8.81e-05	0.000378	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—ovarian cancer	8.81e-05	0.000378	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—ovarian cancer	8.8e-05	0.000378	CcSEcCtD
Phenytoin—Nausea—Paclitaxel—ovarian cancer	8.78e-05	0.000377	CcSEcCtD
Phenytoin—ABCB1—female gonad—ovarian cancer	8.74e-05	0.00777	CbGeAlD
Phenytoin—Discomfort—Epirubicin—ovarian cancer	8.71e-05	0.000374	CcSEcCtD
Phenytoin—ABCB1—vagina—ovarian cancer	8.69e-05	0.00772	CbGeAlD
Phenytoin—Malaise—Doxorubicin—ovarian cancer	8.64e-05	0.000371	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—ovarian cancer	8.62e-05	0.00037	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—ovarian cancer	8.61e-05	0.000369	CcSEcCtD
Phenytoin—Syncope—Doxorubicin—ovarian cancer	8.59e-05	0.000369	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—ovarian cancer	8.57e-05	0.000368	CcSEcCtD
Phenytoin—Diarrhoea—Docetaxel—ovarian cancer	8.57e-05	0.000368	CcSEcCtD
Phenytoin—Confusional state—Epirubicin—ovarian cancer	8.52e-05	0.000366	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—ovarian cancer	8.47e-05	0.000363	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—ovarian cancer	8.45e-05	0.000363	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—ovarian cancer	8.42e-05	0.000361	CcSEcCtD
Phenytoin—Infection—Epirubicin—ovarian cancer	8.39e-05	0.00036	CcSEcCtD
Phenytoin—Cough—Doxorubicin—ovarian cancer	8.36e-05	0.000359	CcSEcCtD
Phenytoin—Shock—Epirubicin—ovarian cancer	8.31e-05	0.000357	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—ovarian cancer	8.3e-05	0.000356	CcSEcCtD
Phenytoin—Nervous system disorder—Epirubicin—ovarian cancer	8.29e-05	0.000356	CcSEcCtD
Phenytoin—Dizziness—Docetaxel—ovarian cancer	8.28e-05	0.000356	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—ovarian cancer	8.27e-05	0.000355	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—ovarian cancer	8.27e-05	0.000355	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—ovarian cancer	8.25e-05	0.000354	CcSEcCtD
Phenytoin—Hyperhidrosis—Epirubicin—ovarian cancer	8.17e-05	0.000351	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—ovarian cancer	8.16e-05	0.00035	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—ovarian cancer	8.16e-05	0.00035	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—ovarian cancer	8.16e-05	0.00035	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—ovarian cancer	8.06e-05	0.000346	CcSEcCtD
Phenytoin—Anorexia—Epirubicin—ovarian cancer	8.05e-05	0.000346	CcSEcCtD
Phenytoin—Dry mouth—Doxorubicin—ovarian cancer	7.98e-05	0.000342	CcSEcCtD
Phenytoin—Vomiting—Docetaxel—ovarian cancer	7.96e-05	0.000342	CcSEcCtD
Phenytoin—Rash—Docetaxel—ovarian cancer	7.9e-05	0.000339	CcSEcCtD
Phenytoin—Hypotension—Epirubicin—ovarian cancer	7.9e-05	0.000339	CcSEcCtD
Phenytoin—Dermatitis—Docetaxel—ovarian cancer	7.89e-05	0.000339	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—ovarian cancer	7.88e-05	0.000338	CcSEcCtD
Phenytoin—Headache—Docetaxel—ovarian cancer	7.85e-05	0.000337	CcSEcCtD
Phenytoin—Anaphylactic shock—Doxorubicin—ovarian cancer	7.82e-05	0.000336	CcSEcCtD
Phenytoin—Infection—Doxorubicin—ovarian cancer	7.77e-05	0.000333	CcSEcCtD
Phenytoin—ABCB1—testis—ovarian cancer	7.75e-05	0.00689	CbGeAlD
Phenytoin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	7.7e-05	0.00033	CcSEcCtD
Phenytoin—Shock—Doxorubicin—ovarian cancer	7.69e-05	0.00033	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—ovarian cancer	7.67e-05	0.000329	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—ovarian cancer	7.65e-05	0.000329	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—ovarian cancer	7.64e-05	0.000328	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—ovarian cancer	7.63e-05	0.000328	CcSEcCtD
Phenytoin—Paraesthesia—Epirubicin—ovarian cancer	7.59e-05	0.000326	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—ovarian cancer	7.56e-05	0.000324	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—ovarian cancer	7.53e-05	0.000323	CcSEcCtD
Phenytoin—Somnolence—Epirubicin—ovarian cancer	7.51e-05	0.000322	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—ovarian cancer	7.45e-05	0.00032	CcSEcCtD
Phenytoin—Nausea—Docetaxel—ovarian cancer	7.44e-05	0.000319	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—ovarian cancer	7.44e-05	0.000319	CcSEcCtD
Phenytoin—Decreased appetite—Epirubicin—ovarian cancer	7.34e-05	0.000315	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—ovarian cancer	7.31e-05	0.000314	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Epirubicin—ovarian cancer	7.29e-05	0.000313	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—ovarian cancer	7.28e-05	0.000313	CcSEcCtD
Phenytoin—Constipation—Epirubicin—ovarian cancer	7.23e-05	0.00031	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	7.12e-05	0.000306	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—ovarian cancer	7.07e-05	0.000304	CcSEcCtD
Phenytoin—Paraesthesia—Doxorubicin—ovarian cancer	7.02e-05	0.000301	CcSEcCtD
Phenytoin—Dyspnoea—Doxorubicin—ovarian cancer	6.97e-05	0.000299	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—ovarian cancer	6.96e-05	0.000299	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—ovarian cancer	6.95e-05	0.000298	CcSEcCtD
Phenytoin—Dyspepsia—Doxorubicin—ovarian cancer	6.88e-05	0.000295	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—ovarian cancer	6.8e-05	0.000292	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	6.75e-05	0.00029	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—ovarian cancer	6.74e-05	0.000289	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—ovarian cancer	6.71e-05	0.000288	CcSEcCtD
Phenytoin—Constipation—Doxorubicin—ovarian cancer	6.69e-05	0.000287	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—ovarian cancer	6.68e-05	0.000287	CcSEcCtD
Phenytoin—Feeling abnormal—Doxorubicin—ovarian cancer	6.44e-05	0.000277	CcSEcCtD
Phenytoin—Hypersensitivity—Epirubicin—ovarian cancer	6.23e-05	0.000267	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—ovarian cancer	6.21e-05	0.000267	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—ovarian cancer	6.18e-05	0.000265	CcSEcCtD
Phenytoin—Asthenia—Epirubicin—ovarian cancer	6.06e-05	0.00026	CcSEcCtD
Phenytoin—Pruritus—Epirubicin—ovarian cancer	5.98e-05	0.000257	CcSEcCtD
Phenytoin—Diarrhoea—Epirubicin—ovarian cancer	5.78e-05	0.000248	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—ovarian cancer	5.76e-05	0.000247	CcSEcCtD
Phenytoin—ABCB1—lymph node—ovarian cancer	5.62e-05	0.005	CbGeAlD
Phenytoin—Asthenia—Doxorubicin—ovarian cancer	5.61e-05	0.000241	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—ovarian cancer	5.59e-05	0.00024	CcSEcCtD
Phenytoin—Pruritus—Doxorubicin—ovarian cancer	5.53e-05	0.000237	CcSEcCtD
Phenytoin—Vomiting—Epirubicin—ovarian cancer	5.37e-05	0.000231	CcSEcCtD
Phenytoin—Diarrhoea—Doxorubicin—ovarian cancer	5.35e-05	0.00023	CcSEcCtD
Phenytoin—Rash—Epirubicin—ovarian cancer	5.33e-05	0.000229	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—ovarian cancer	5.32e-05	0.000228	CcSEcCtD
Phenytoin—Headache—Epirubicin—ovarian cancer	5.29e-05	0.000227	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—ovarian cancer	5.17e-05	0.000222	CcSEcCtD
Phenytoin—Nausea—Epirubicin—ovarian cancer	5.02e-05	0.000215	CcSEcCtD
Phenytoin—Vomiting—Doxorubicin—ovarian cancer	4.97e-05	0.000213	CcSEcCtD
Phenytoin—Rash—Doxorubicin—ovarian cancer	4.93e-05	0.000212	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—ovarian cancer	4.92e-05	0.000211	CcSEcCtD
Phenytoin—Headache—Doxorubicin—ovarian cancer	4.9e-05	0.00021	CcSEcCtD
Phenytoin—Nausea—Doxorubicin—ovarian cancer	4.64e-05	0.000199	CcSEcCtD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.48e-05	0.000455	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MAPK3—ovarian cancer	1.47e-05	0.000454	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—AKT1—ovarian cancer	1.46e-05	0.000451	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—AKT1—ovarian cancer	1.46e-05	0.000451	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.46e-05	0.000451	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.45e-05	0.000448	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—SOD1—ovarian cancer	1.44e-05	0.000445	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PPP2R1A—ovarian cancer	1.44e-05	0.000443	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.43e-05	0.000441	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.43e-05	0.00044	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—YAP1—ovarian cancer	1.42e-05	0.000438	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—AKT1—ovarian cancer	1.41e-05	0.000435	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PPP2R1A—ovarian cancer	1.41e-05	0.000434	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MAPK1—ovarian cancer	1.4e-05	0.000432	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—EGFR—ovarian cancer	1.4e-05	0.000431	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—CAV1—ovarian cancer	1.4e-05	0.000431	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYTB—ovarian cancer	1.35e-05	0.000418	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.34e-05	0.000412	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.33e-05	0.000409	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.33e-05	0.000409	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.33e-05	0.000409	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.33e-05	0.000409	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.32e-05	0.000408	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYTB—ovarian cancer	1.32e-05	0.000408	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—KRAS—ovarian cancer	1.32e-05	0.000408	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.32e-05	0.000407	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PPP1CC—ovarian cancer	1.32e-05	0.000407	CbGpPWpGaD
Phenytoin—ALB—Metabolism—BRIP1—ovarian cancer	1.32e-05	0.000407	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.31e-05	0.000405	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ABCB1—ovarian cancer	1.31e-05	0.000403	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.29e-05	0.000399	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—TYMS—ovarian cancer	1.28e-05	0.000396	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.28e-05	0.000395	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CG—ovarian cancer	1.27e-05	0.000393	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NME2—ovarian cancer	1.26e-05	0.00039	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.26e-05	0.000389	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.25e-05	0.000385	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYTB—ovarian cancer	1.24e-05	0.000381	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.22e-05	0.000375	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.21e-05	0.000372	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.18e-05	0.000365	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.18e-05	0.000365	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—FASN—ovarian cancer	1.16e-05	0.000357	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.16e-05	0.000356	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—BRIP1—ovarian cancer	1.16e-05	0.000356	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.16e-05	0.000356	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.14e-05	0.000351	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—HRAS—ovarian cancer	1.12e-05	0.000346	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CD—ovarian cancer	1.12e-05	0.000345	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.12e-05	0.000344	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.1e-05	0.000339	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.1e-05	0.000339	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.08e-05	0.000333	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.08e-05	0.000333	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—IL6—ovarian cancer	1.08e-05	0.000332	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—CAV1—ovarian cancer	1.06e-05	0.000326	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.06e-05	0.000326	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.06e-05	0.000325	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—YAP1—ovarian cancer	1.05e-05	0.000324	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.04e-05	0.000321	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CAV1—ovarian cancer	1.03e-05	0.000319	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—YAP1—ovarian cancer	1.03e-05	0.000317	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.01e-05	0.000312	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1e-05	0.00031	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—AKT1—ovarian cancer	9.92e-06	0.000306	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.89e-06	0.000305	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.89e-06	0.000305	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CB—ovarian cancer	9.75e-06	0.000301	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.67e-06	0.000298	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CG—ovarian cancer	9.62e-06	0.000297	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.61e-06	0.000296	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CG—ovarian cancer	9.42e-06	0.000291	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	9.36e-06	0.000289	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.34e-06	0.000288	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—YAP1—ovarian cancer	8.9e-06	0.000274	CbGpPWpGaD
Phenytoin—ALB—Metabolism—YAP1—ovarian cancer	8.85e-06	0.000273	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.81e-06	0.000272	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.76e-06	0.00027	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	8.72e-06	0.000269	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ABCB1—ovarian cancer	8.69e-06	0.000268	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.63e-06	0.000266	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.58e-06	0.000265	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—FASN—ovarian cancer	8.57e-06	0.000264	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—TYMS—ovarian cancer	8.53e-06	0.000263	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CD—ovarian cancer	8.46e-06	0.000261	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—SLC5A5—ovarian cancer	8.43e-06	0.00026	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PTEN—ovarian cancer	8.43e-06	0.00026	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—FASN—ovarian cancer	8.38e-06	0.000258	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.3e-06	0.000256	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CD—ovarian cancer	8.28e-06	0.000255	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—SLC5A5—ovarian cancer	8.24e-06	0.000254	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYTB—ovarian cancer	8.15e-06	0.000251	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—SLC2A1—ovarian cancer	8.14e-06	0.000251	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—SLC2A1—ovarian cancer	7.96e-06	0.000245	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—YAP1—ovarian cancer	7.94e-06	0.000245	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.87e-06	0.000243	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.86e-06	0.000242	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP1B1—ovarian cancer	7.8e-06	0.000241	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—YAP1—ovarian cancer	7.75e-06	0.000239	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.74e-06	0.000239	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.7e-06	0.000237	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP1B1—ovarian cancer	7.63e-06	0.000235	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CB—ovarian cancer	7.37e-06	0.000227	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—FASN—ovarian cancer	7.25e-06	0.000224	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—YAP1—ovarian cancer	7.24e-06	0.000223	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CB—ovarian cancer	7.22e-06	0.000223	CbGpPWpGaD
Phenytoin—ALB—Metabolism—FASN—ovarian cancer	7.21e-06	0.000222	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.17e-06	0.000221	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.14e-06	0.00022	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.12e-06	0.00022	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.12e-06	0.00022	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.12e-06	0.00022	CbGpPWpGaD
Phenytoin—ALB—Metabolism—SLC5A5—ovarian cancer	7.1e-06	0.000219	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.01e-06	0.000216	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	6.92e-06	0.000213	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.91e-06	0.000213	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—SLC2A1—ovarian cancer	6.89e-06	0.000213	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CAV1—ovarian cancer	6.88e-06	0.000212	CbGpPWpGaD
Phenytoin—ALB—Metabolism—SLC2A1—ovarian cancer	6.85e-06	0.000211	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IL2—ovarian cancer	6.77e-06	0.000209	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	6.77e-06	0.000209	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.75e-06	0.000208	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.71e-06	0.000207	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP1B1—ovarian cancer	6.61e-06	0.000204	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP1B1—ovarian cancer	6.57e-06	0.000203	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—FASN—ovarian cancer	6.48e-06	0.0002	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ABCB1—ovarian cancer	6.43e-06	0.000198	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.37e-06	0.000196	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—FASN—ovarian cancer	6.32e-06	0.000195	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—TYMS—ovarian cancer	6.31e-06	0.000195	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.3e-06	0.000194	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ABCB1—ovarian cancer	6.28e-06	0.000194	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CG—ovarian cancer	6.26e-06	0.000193	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PTEN—ovarian cancer	6.24e-06	0.000192	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.22e-06	0.000192	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—TYMS—ovarian cancer	6.17e-06	0.00019	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.15e-06	0.00019	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.02e-06	0.000186	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SLC2A1—ovarian cancer	6e-06	0.000185	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—PIK3CA—ovarian cancer	5.95e-06	0.000183	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—FASN—ovarian cancer	5.9e-06	0.000182	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP1B1—ovarian cancer	5.9e-06	0.000182	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.86e-06	0.000181	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.83e-06	0.00018	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PPP2R1A—ovarian cancer	5.83e-06	0.00018	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.81e-06	0.000179	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.8e-06	0.000179	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.76e-06	0.000178	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VEGFA—ovarian cancer	5.75e-06	0.000177	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NRAS—ovarian cancer	5.68e-06	0.000175	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.61e-06	0.000173	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CD—ovarian cancer	5.51e-06	0.00017	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.49e-06	0.000169	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—MAPK3—ovarian cancer	5.44e-06	0.000168	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.44e-06	0.000168	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ABCB1—ovarian cancer	5.41e-06	0.000167	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.38e-06	0.000166	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TYMS—ovarian cancer	5.34e-06	0.000165	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TYMS—ovarian cancer	5.31e-06	0.000164	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.23e-06	0.000161	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.2e-06	0.00016	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—MAPK1—ovarian cancer	5.18e-06	0.00016	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.11e-06	0.000157	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CAV1—ovarian cancer	5.09e-06	0.000157	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CAV1—ovarian cancer	4.97e-06	0.000153	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KRAS—ovarian cancer	4.89e-06	0.000151	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—AKT1—ovarian cancer	4.86e-06	0.00015	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.86e-06	0.00015	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CB—ovarian cancer	4.8e-06	0.000148	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—YAP1—ovarian cancer	4.78e-06	0.000147	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TYMS—ovarian cancer	4.77e-06	0.000147	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.77e-06	0.000147	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.75e-06	0.000146	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TYMS—ovarian cancer	4.66e-06	0.000144	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CG—ovarian cancer	4.63e-06	0.000143	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.53e-06	0.00014	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PIK3CA—ovarian cancer	4.49e-06	0.000139	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.43e-06	0.000137	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—PIK3CA—ovarian cancer	4.4e-06	0.000136	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TYMS—ovarian cancer	4.35e-06	0.000134	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—ovarian cancer	4.35e-06	0.000134	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CAV1—ovarian cancer	4.31e-06	0.000133	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CAV1—ovarian cancer	4.28e-06	0.000132	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HRAS—ovarian cancer	4.16e-06	0.000128	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PTEN—ovarian cancer	4.15e-06	0.000128	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.11e-06	0.000127	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.09e-06	0.000126	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CD—ovarian cancer	4.07e-06	0.000126	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.98e-06	0.000123	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.92e-06	0.000121	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CG—ovarian cancer	3.9e-06	0.00012	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—FASN—ovarian cancer	3.89e-06	0.00012	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CAV1—ovarian cancer	3.84e-06	0.000119	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.83e-06	0.000118	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CAV1—ovarian cancer	3.75e-06	0.000116	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.7e-06	0.000114	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.67e-06	0.000113	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—AKT1—ovarian cancer	3.67e-06	0.000113	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—AKT1—ovarian cancer	3.6e-06	0.000111	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.55e-06	0.000109	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.55e-06	0.000109	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CAV1—ovarian cancer	3.5e-06	0.000108	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.5e-06	0.000108	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.47e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.45e-06	0.000106	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CD—ovarian cancer	3.43e-06	0.000106	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.42e-06	0.000105	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.35e-06	0.000103	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.19e-06	9.84e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.15e-06	9.7e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.08e-06	9.49e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PTEN—ovarian cancer	3.07e-06	9.46e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.01e-06	9.27e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CD—ovarian cancer	3e-06	9.26e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PTEN—ovarian cancer	3e-06	9.25e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CB—ovarian cancer	2.99e-06	9.21e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.93e-06	9.02e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.92e-06	9.01e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TYMS—ovarian cancer	2.87e-06	8.84e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.81e-06	8.65e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.68e-06	8.27e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.62e-06	8.07e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PTEN—ovarian cancer	2.6e-06	8.01e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PTEN—ovarian cancer	2.58e-06	7.96e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.45e-06	7.54e-05	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—AKT1—ovarian cancer	2.39e-06	7.37e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PTEN—ovarian cancer	2.32e-06	7.15e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CAV1—ovarian cancer	2.31e-06	7.13e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PTEN—ovarian cancer	2.26e-06	6.98e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.16e-06	6.67e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.12e-06	6.52e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PTEN—ovarian cancer	2.11e-06	6.52e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.11e-06	6.49e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.85e-06	5.71e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.83e-06	5.65e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PIK3CA—ovarian cancer	1.82e-06	5.62e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—AKT1—ovarian cancer	1.77e-06	5.45e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—AKT1—ovarian cancer	1.73e-06	5.33e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.64e-06	5.04e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.61e-06	4.97e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.6e-06	4.92e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—AKT1—ovarian cancer	1.5e-06	4.62e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.49e-06	4.6e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—AKT1—ovarian cancer	1.49e-06	4.59e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PTEN—ovarian cancer	1.39e-06	4.3e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—AKT1—ovarian cancer	1.34e-06	4.12e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—AKT1—ovarian cancer	1.3e-06	4.02e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—AKT1—ovarian cancer	1.22e-06	3.76e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	9.83e-07	3.03e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AKT1—ovarian cancer	8.03e-07	2.48e-05	CbGpPWpGaD
